Cargando…

Exercise Alleviates Osteoporosis in Rats with Mild Chronic Kidney Disease by Decreasing Sclerostin Production

Chronic kidney disease–mineral bone disorder (CKD–MBD), comprising mineral, hormonal, and bone metabolic imbalance, is a major CKD-related issue; it causes osteoporosis prevalence in CKD patients. Osteocyte-derived sclerostin inhibits the osteogenic Wnt/β-catenin signaling pathway; its levels rise w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Hung-Wei, Huang, Tsang-Hai, Chang, Yi-Han, Liou, Hung-Hsiang, Chou, Yu-Hsien, Sue, Yuh-Mou, Hung, Peir-Haur, Chang, Yu-Tzu, Ho, Pei-Chuan, Tsai, Kuen-Jer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514556/ https://www.ncbi.nlm.nih.gov/pubmed/31027235 http://dx.doi.org/10.3390/ijms20082044

Ejemplares similares

Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy
por: Liao, Hung-Wei, et al.
Publicado: (2015)

Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients
por: Chang, Yu-Chi, et al.
Publicado: (2018)

Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study
por: Kuo, Te-Hui, et al.
Publicado: (2019)

Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study
por: Hung, Peir-Haur, et al.
Publicado: (2019)

Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan
por: Hung, Peir‐Haur, et al.
Publicado: (2021)

Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder
por: Chen, Tsung-Hsien, et al.
Publicado: (2023)

End stage renal disease is associated with development of dementia
por: Hung, Peir-Haur, et al.
Publicado: (2017)

Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients
por: Wu, Chun-Feng, et al.
Publicado: (2020)

Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016)

Abdominal Obesity is Associated with Peripheral Artery Disease in Hemodialysis Patients
por: Hung, Peir-Haur, et al.
Publicado: (2013)

Increased Risk of End-Stage Renal Disease in Patients with Renal Cell Carcinoma: A 12-Year Nationwide Follow-Up Study
por: Hung, Peir-Haur, et al.
Publicado: (2014)

Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy
por: Hung, Peir-Haur, et al.
Publicado: (2016)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Involvement of MicroRNA-296 in the Inhibitory Effect of Epigallocatechin Gallate against the Migratory Properties of Anoikis-Resistant Nasopharyngeal Carcinoma Cells
por: Lin, Chien-Hung, et al.
Publicado: (2020)

CD44 Is Associated with the Aggressive Phenotype of Nasopharyngeal Carcinoma through Redox Regulation
por: Lin, Chien-Hung, et al.
Publicado: (2013)

Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study
por: Hsu, Bang-Gee, et al.
Publicado: (2016)

Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis
por: Hung, Peir-Haur, et al.
Publicado: (2021)

Glycated Hemoglobin < 6.5% Is Associated With Uroseptic Shock in Diabetic Patients With Urinary Tract Infection
por: Lee, Yi-Chien, et al.
Publicado: (2020)

Association of Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and Incidence of Gout in Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2021)

Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
por: Fabre, Stéphanie, et al.
Publicado: (2020)

Novel Aptamer-Based Small-Molecule Drug Screening Assay to Identify Potential Sclerostin Inhibitors against Osteoporosis
por: Lee, Chien-Ching, et al.
Publicado: (2021)

Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines
por: Lin, Chien-Hung, et al.
Publicado: (2012)

Risk Factors for Development of Acute Kidney Injury in Patients with Urinary Tract Infection
por: Hsiao, Chih-Yen, et al.
Publicado: (2015)

Correlation Between Bladder Pain Syndrome/Interstitial Cystitis and Pelvic Inflammatory Disease
por: Chung, Shiu-Dong, et al.
Publicado: (2015)

Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and the Incidence of Acute Kidney Injury in Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2023)

Risk factors for uroseptic shock in hospitalized patients aged over 80 years with urinary tract infection
por: Hsiao, Chih-Yen, et al.
Publicado: (2020)

Infections and risk of end-stage renal disease in patients with nephrotic syndrome: a nationwide population-based case-control study
por: Lin, Chien-Hung, et al.
Publicado: (2020)

The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation
por: Hung, Peir-Haur, et al.
Publicado: (2022)

Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis
por: Shah, Arti D, et al.
Publicado: (2015)

Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges
por: MacNabb, Claire, et al.
Publicado: (2016)

Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
por: Thiele, Sylvia, et al.
Publicado: (2019)

Sclerostin Inhibition: A Novel Target for the Treatment of Postmenopausal Osteoporosis
por: Aditya, Suruchi, et al.
Publicado: (2021)

Association of SGLT2 inhibitors with lower incidence of death in type 2 diabetes mellitus and causes of death analysis
por: Chung, Mu-Chi, et al.
Publicado: (2022)

Close correlation between the ankle-brachial index and symptoms of depression in hemodialysis patients
por: Jong, Ing-Chin, et al.
Publicado: (2017)

Inverted U-Curve Association between Serum Indoxyl Sulfate Levels and Cardiovascular Events in Patients on Chronic Hemodialysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2021)

Osteoporosis Treatment with Anti-Sclerostin Antibodies—Mechanisms of Action and Clinical Application
por: Rauner, Martina, et al.
Publicado: (2021)

Sclerostin as a biomarker of physical exercise in osteoporosis: A narrative review
por: Oniszczuk, Anna, et al.
Publicado: (2022)

Urolithiasis Is a Risk Factor for Uroseptic Shock and Acute Kidney Injury in Patients With Urinary Tract Infection
por: Hsiao, Chih-Yen, et al.
Publicado: (2019)

Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2020)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9sqcjo4ada2q69tesvb01l04gu